ADAPTHEALTH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.35 USD | +2.88% |
|
+8.04% | +41.98% |
| Apr. 17 | AdaptHealth Names Suzanne Foster as CEO | MT |
| Apr. 17 | AdaptHealth Names Suzanne Foster CEO | DJ |
Financials (USD)
| Sales 2024 * | 3.32B | Sales 2025 * | 3.52B | Capitalization | 1.39B |
|---|---|---|---|---|---|
| Net income 2024 * | 104M | Net income 2025 * | 131M | EV / Sales 2024 * | 1.02 x |
| Net Debt 2024 * | 1.98B | Net Debt 2025 * | 1.98B | EV / Sales 2025 * | 0.96 x |
| P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
10.6
x | Employees | 10,700 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on AdaptHealth Corp.
More press releases
| 1 day | +2.88% | ||
| 1 week | +8.04% | ||
| Current month | +5.08% | ||
| 1 month | -4.08% | ||
| 3 months | +38.55% | ||
| 6 months | +36.18% | ||
| Current year | +41.98% |
1 week
9.71
10.44
1 month
9.0911.07
Current year
6.4611.73
1 year
6.3715.37
3 years
6.3730.33
5 years
6.3741.58
10 years
6.3741.58
| Managers | Title | Age | Since |
|---|---|---|---|
Richard Barasch
CEO | Chief Executive Officer | 70 | 11-12-31 |
Jason Clemens
DFI | Director of Finance/CFO | 46 | 20-08-02 |
Joshua Parnes
PSD | President | 46 | 19-11-07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Richard Barasch
CEO | Chief Executive Officer | 70 | 11-12-31 |
Dale Wolf
BRD | Director/Board Member | 69 | 19-11-07 |
Ted Lundberg
BRD | Director/Board Member | 49 | 21-02-01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.90% | 12 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 10.35 | +2.88% | 1,026,821 |
| 24-05-01 | 10.06 | +2.13% | 738,740 |
| 24-04-30 | 9.85 | -2.76% | 843,997 |
| 24-04-29 | 10.13 | +1.71% | 986,270 |
| 24-04-26 | 9.96 | +3.97% | 1,053,761 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotes
Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.
Calendar
2024-05-06
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
10.35
USD
Average target price
11.85
USD
Spread / Average Target
+14.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +41.98% | 1.39B | |
| -3.77% | 184B | |
| -1.77% | 107B | |
| -1.43% | 69.44B | |
| +2.06% | 50.37B | |
| +9.43% | 44.82B | |
| +3.40% | 41.53B | |
| +3.04% | 26.73B | |
| +4.64% | 26.84B | |
| +15.23% | 25.71B |
- Stock Market
- Equities
- AHCO Stock
